nodes	percent_of_prediction	percent_of_DWPC	metapath
Gadoxetate—Distention—Metformin—polycystic ovary syndrome	0.074	0.132	CcSEcCtD
Gadoxetate—Abdominal bloating—Metformin—polycystic ovary syndrome	0.0366	0.0654	CcSEcCtD
Gadoxetate—Epigastric discomfort—Metformin—polycystic ovary syndrome	0.0332	0.0593	CcSEcCtD
Gadoxetate—Acidosis—Metformin—polycystic ovary syndrome	0.0315	0.0563	CcSEcCtD
Gadoxetate—Respiratory distress—Metformin—polycystic ovary syndrome	0.0275	0.0491	CcSEcCtD
Gadoxetate—ABCC3—ABC-family proteins mediated transport—ABCB6—polycystic ovary syndrome	0.0199	0.0549	CbGpPWpGaD
Gadoxetate—ABCC4—ABC-family proteins mediated transport—ABCB6—polycystic ovary syndrome	0.0187	0.0516	CbGpPWpGaD
Gadoxetate—ABCC2—ABC-family proteins mediated transport—ABCB6—polycystic ovary syndrome	0.0158	0.0435	CbGpPWpGaD
Gadoxetate—Lightheadedness—Metformin—polycystic ovary syndrome	0.0156	0.0279	CcSEcCtD
Gadoxetate—SLCO1B3—Bile acid and bile salt metabolism—AKR1C2—polycystic ovary syndrome	0.0142	0.0392	CbGpPWpGaD
Gadoxetate—Renal impairment—Metformin—polycystic ovary syndrome	0.0133	0.0238	CcSEcCtD
Gadoxetate—ABCC3—Bile acid and bile salt metabolism—AKR1C2—polycystic ovary syndrome	0.0128	0.0354	CbGpPWpGaD
Gadoxetate—ABCC3—Drug Induction of Bile Acid Pathway—SULT2A1—polycystic ovary syndrome	0.012	0.033	CbGpPWpGaD
Gadoxetate—Dehydration—Metformin—polycystic ovary syndrome	0.0118	0.021	CcSEcCtD
Gadoxetate—ABCC4—Drug Induction of Bile Acid Pathway—SULT2A1—polycystic ovary syndrome	0.0113	0.031	CbGpPWpGaD
Gadoxetate—Abdominal distension—Metformin—polycystic ovary syndrome	0.011	0.0197	CcSEcCtD
Gadoxetate—Sweating increased—Metformin—polycystic ovary syndrome	0.0107	0.019	CcSEcCtD
Gadoxetate—ABCC4—Ectoderm Differentiation—RHPN1—polycystic ovary syndrome	0.00992	0.0273	CbGpPWpGaD
Gadoxetate—SLCO1B1—Bile acid and bile salt metabolism—AKR1C2—polycystic ovary syndrome	0.00956	0.0264	CbGpPWpGaD
Gadoxetate—ABCC2—Drug Induction of Bile Acid Pathway—SULT2A1—polycystic ovary syndrome	0.00949	0.0262	CbGpPWpGaD
Gadoxetate—SLCO1B3—pituitary gland—polycystic ovary syndrome	0.00922	0.119	CbGeAlD
Gadoxetate—SLCO1B1—Drug Induction of Bile Acid Pathway—SULT2A1—polycystic ovary syndrome	0.00892	0.0246	CbGpPWpGaD
Gadoxetate—Rhinitis—Metformin—polycystic ovary syndrome	0.00878	0.0157	CcSEcCtD
Gadoxetate—Hypoaesthesia—Metformin—polycystic ovary syndrome	0.00871	0.0156	CcSEcCtD
Gadoxetate—Connective tissue disorder—Metformin—polycystic ovary syndrome	0.00861	0.0154	CcSEcCtD
Gadoxetate—Cardiac disorder—Metformin—polycystic ovary syndrome	0.00813	0.0145	CcSEcCtD
Gadoxetate—Flushing—Metformin—polycystic ovary syndrome	0.00813	0.0145	CcSEcCtD
Gadoxetate—Angiopathy—Metformin—polycystic ovary syndrome	0.00795	0.0142	CcSEcCtD
Gadoxetate—SLCO1B3—Bile acid and bile salt metabolism—AKR1C1—polycystic ovary syndrome	0.00791	0.0218	CbGpPWpGaD
Gadoxetate—Immune system disorder—Metformin—polycystic ovary syndrome	0.00791	0.0141	CcSEcCtD
Gadoxetate—Mediastinal disorder—Metformin—polycystic ovary syndrome	0.00789	0.0141	CcSEcCtD
Gadoxetate—Chills—Metformin—polycystic ovary syndrome	0.00786	0.014	CcSEcCtD
Gadoxetate—SLCO1B3—vagina—polycystic ovary syndrome	0.00763	0.0983	CbGeAlD
Gadoxetate—Flatulence—Metformin—polycystic ovary syndrome	0.00751	0.0134	CcSEcCtD
Gadoxetate—Dysgeusia—Metformin—polycystic ovary syndrome	0.00747	0.0133	CcSEcCtD
Gadoxetate—ABCC3—Constitutive Androstane Receptor Pathway—SULT2A1—polycystic ovary syndrome	0.00722	0.0199	CbGpPWpGaD
Gadoxetate—Vision blurred—Metformin—polycystic ovary syndrome	0.00718	0.0128	CcSEcCtD
Gadoxetate—Tremor—Metformin—polycystic ovary syndrome	0.00714	0.0128	CcSEcCtD
Gadoxetate—SLCO1B3—endocrine gland—polycystic ovary syndrome	0.00714	0.0919	CbGeAlD
Gadoxetate—ABCC3—Bile acid and bile salt metabolism—AKR1C1—polycystic ovary syndrome	0.00714	0.0197	CbGpPWpGaD
Gadoxetate—Ill-defined disorder—Metformin—polycystic ovary syndrome	0.00707	0.0126	CcSEcCtD
Gadoxetate—Malaise—Metformin—polycystic ovary syndrome	0.00687	0.0123	CcSEcCtD
Gadoxetate—Syncope—Metformin—polycystic ovary syndrome	0.00684	0.0122	CcSEcCtD
Gadoxetate—ABCC3—Fluoropyrimidine Activity—RRM2—polycystic ovary syndrome	0.00682	0.0188	CbGpPWpGaD
Gadoxetate—Palpitations—Metformin—polycystic ovary syndrome	0.00674	0.012	CcSEcCtD
Gadoxetate—Loss of consciousness—Metformin—polycystic ovary syndrome	0.0067	0.012	CcSEcCtD
Gadoxetate—Chest pain—Metformin—polycystic ovary syndrome	0.00649	0.0116	CcSEcCtD
Gadoxetate—Unspecified disorder of skin and subcutaneous tissue—Metformin—polycystic ovary syndrome	0.00645	0.0115	CcSEcCtD
Gadoxetate—ABCC4—Fluoropyrimidine Activity—RRM2—polycystic ovary syndrome	0.00641	0.0177	CbGpPWpGaD
Gadoxetate—Discomfort—Metformin—polycystic ovary syndrome	0.00641	0.0115	CcSEcCtD
Gadoxetate—ABCC4—Ectoderm Differentiation—TOX3—polycystic ovary syndrome	0.00639	0.0176	CbGpPWpGaD
Gadoxetate—ABCC3—adrenal cortex—polycystic ovary syndrome	0.00626	0.0806	CbGeAlD
Gadoxetate—Oedema—Metformin—polycystic ovary syndrome	0.00622	0.0111	CcSEcCtD
Gadoxetate—Infection—Metformin—polycystic ovary syndrome	0.00618	0.011	CcSEcCtD
Gadoxetate—Shock—Metformin—polycystic ovary syndrome	0.00612	0.0109	CcSEcCtD
Gadoxetate—Nervous system disorder—Metformin—polycystic ovary syndrome	0.0061	0.0109	CcSEcCtD
Gadoxetate—SLCO1B3—Bile acid and bile salt metabolism—AKR1C3—polycystic ovary syndrome	0.00609	0.0168	CbGpPWpGaD
Gadoxetate—Skin disorder—Metformin—polycystic ovary syndrome	0.00604	0.0108	CcSEcCtD
Gadoxetate—Hyperhidrosis—Metformin—polycystic ovary syndrome	0.00601	0.0107	CcSEcCtD
Gadoxetate—Anorexia—Metformin—polycystic ovary syndrome	0.00593	0.0106	CcSEcCtD
Gadoxetate—Hypotension—Metformin—polycystic ovary syndrome	0.00581	0.0104	CcSEcCtD
Gadoxetate—ABCC2—Constitutive Androstane Receptor Pathway—SULT2A1—polycystic ovary syndrome	0.00572	0.0158	CbGpPWpGaD
Gadoxetate—Paraesthesia—Metformin—polycystic ovary syndrome	0.00559	0.00998	CcSEcCtD
Gadoxetate—Dyspnoea—Metformin—polycystic ovary syndrome	0.00555	0.00991	CcSEcCtD
Gadoxetate—ABCC3—Bile acid and bile salt metabolism—AKR1C3—polycystic ovary syndrome	0.0055	0.0152	CbGpPWpGaD
Gadoxetate—Decreased appetite—Metformin—polycystic ovary syndrome	0.00541	0.00966	CcSEcCtD
Gadoxetate—Gastrointestinal disorder—Metformin—polycystic ovary syndrome	0.00537	0.0096	CcSEcCtD
Gadoxetate—Fatigue—Metformin—polycystic ovary syndrome	0.00536	0.00959	CcSEcCtD
Gadoxetate—Constipation—Metformin—polycystic ovary syndrome	0.00532	0.00951	CcSEcCtD
Gadoxetate—SLCO1B1—Bile acid and bile salt metabolism—AKR1C1—polycystic ovary syndrome	0.00532	0.0147	CbGpPWpGaD
Gadoxetate—Feeling abnormal—Metformin—polycystic ovary syndrome	0.00513	0.00916	CcSEcCtD
Gadoxetate—Gastrointestinal pain—Metformin—polycystic ovary syndrome	0.00509	0.00909	CcSEcCtD
Gadoxetate—ABCC3—adipose tissue—polycystic ovary syndrome	0.00504	0.0649	CbGeAlD
Gadoxetate—Urticaria—Metformin—polycystic ovary syndrome	0.00494	0.00883	CcSEcCtD
Gadoxetate—Abdominal pain—Metformin—polycystic ovary syndrome	0.00492	0.00879	CcSEcCtD
Gadoxetate—ABCC3—adrenal gland—polycystic ovary syndrome	0.00452	0.0582	CbGeAlD
Gadoxetate—Asthenia—Metformin—polycystic ovary syndrome	0.00446	0.00798	CcSEcCtD
Gadoxetate—Pruritus—Metformin—polycystic ovary syndrome	0.0044	0.00787	CcSEcCtD
Gadoxetate—Diarrhoea—Metformin—polycystic ovary syndrome	0.00426	0.00761	CcSEcCtD
Gadoxetate—ABCC4—uterus—polycystic ovary syndrome	0.00425	0.0547	CbGeAlD
Gadoxetate—ABCC3—female gonad—polycystic ovary syndrome	0.00421	0.0543	CbGeAlD
Gadoxetate—ABCC4—adipose tissue—polycystic ovary syndrome	0.00416	0.0535	CbGeAlD
Gadoxetate—SLCO1B1—endocrine gland—polycystic ovary syndrome	0.00413	0.0532	CbGeAlD
Gadoxetate—Dizziness—Metformin—polycystic ovary syndrome	0.00411	0.00735	CcSEcCtD
Gadoxetate—SLCO1B1—Bile acid and bile salt metabolism—AKR1C3—polycystic ovary syndrome	0.00409	0.0113	CbGpPWpGaD
Gadoxetate—Vomiting—Metformin—polycystic ovary syndrome	0.00396	0.00707	CcSEcCtD
Gadoxetate—Rash—Metformin—polycystic ovary syndrome	0.00392	0.00701	CcSEcCtD
Gadoxetate—Dermatitis—Metformin—polycystic ovary syndrome	0.00392	0.007	CcSEcCtD
Gadoxetate—ABCC3—endocrine gland—polycystic ovary syndrome	0.00392	0.0505	CbGeAlD
Gadoxetate—Headache—Metformin—polycystic ovary syndrome	0.0039	0.00696	CcSEcCtD
Gadoxetate—ABCC4—adrenal gland—polycystic ovary syndrome	0.00373	0.048	CbGeAlD
Gadoxetate—Nausea—Metformin—polycystic ovary syndrome	0.0037	0.0066	CcSEcCtD
Gadoxetate—ABCC2—adrenal gland—polycystic ovary syndrome	0.00361	0.0465	CbGeAlD
Gadoxetate—ABCC4—female gonad—polycystic ovary syndrome	0.00348	0.0448	CbGeAlD
Gadoxetate—ABCC3—Fluoropyrimidine Activity—MTHFR—polycystic ovary syndrome	0.00345	0.00951	CbGpPWpGaD
Gadoxetate—ABCC4—Fluoropyrimidine Activity—MTHFR—polycystic ovary syndrome	0.00324	0.00894	CbGpPWpGaD
Gadoxetate—ABCC4—endocrine gland—polycystic ovary syndrome	0.00323	0.0416	CbGeAlD
Gadoxetate—ABCC2—endocrine gland—polycystic ovary syndrome	0.00313	0.0403	CbGeAlD
Gadoxetate—ABCC4—Platelet activation, signaling and aggregation—GP1BB—polycystic ovary syndrome	0.00312	0.00861	CbGpPWpGaD
Gadoxetate—ABCC3—Nuclear Receptors in Lipid Metabolism and Toxicity—PPARG—polycystic ovary syndrome	0.00273	0.00753	CbGpPWpGaD
Gadoxetate—ABCC4—Ectoderm Differentiation—DMD—polycystic ovary syndrome	0.00262	0.00721	CbGpPWpGaD
Gadoxetate—SLCO1B3—Transmembrane transport of small molecules—ABCB6—polycystic ovary syndrome	0.00231	0.00636	CbGpPWpGaD
Gadoxetate—ABCC2—Nuclear Receptors in Lipid Metabolism and Toxicity—PPARG—polycystic ovary syndrome	0.00217	0.00597	CbGpPWpGaD
Gadoxetate—ABCC3—Transmembrane transport of small molecules—ABCB6—polycystic ovary syndrome	0.00208	0.00574	CbGpPWpGaD
Gadoxetate—SLCO1B3—Metabolism of lipids and lipoproteins—LPCAT2—polycystic ovary syndrome	0.00198	0.00545	CbGpPWpGaD
Gadoxetate—ABCC4—Transmembrane transport of small molecules—ABCB6—polycystic ovary syndrome	0.00196	0.00539	CbGpPWpGaD
Gadoxetate—ABCC3—Metabolism of lipids and lipoproteins—LPCAT2—polycystic ovary syndrome	0.00178	0.00492	CbGpPWpGaD
Gadoxetate—ABCC2—Transmembrane transport of small molecules—ABCB6—polycystic ovary syndrome	0.00165	0.00455	CbGpPWpGaD
Gadoxetate—SLCO1B3—Transmembrane transport of small molecules—TRPV6—polycystic ovary syndrome	0.00164	0.00453	CbGpPWpGaD
Gadoxetate—ABCC4—Hemostasis—GP1BB—polycystic ovary syndrome	0.00161	0.00444	CbGpPWpGaD
Gadoxetate—SLCO1B3—Metabolism of lipids and lipoproteins—AKR1C2—polycystic ovary syndrome	0.00156	0.00431	CbGpPWpGaD
Gadoxetate—SLCO1B3—Metabolism of lipids and lipoproteins—TEAD2—polycystic ovary syndrome	0.00156	0.00431	CbGpPWpGaD
Gadoxetate—SLCO1B1—Transmembrane transport of small molecules—ABCB6—polycystic ovary syndrome	0.00155	0.00427	CbGpPWpGaD
Gadoxetate—SLCO1B3—Transmembrane transport of small molecules—SCNN1A—polycystic ovary syndrome	0.00149	0.0041	CbGpPWpGaD
Gadoxetate—ABCC3—NRF2 pathway—SLC2A4—polycystic ovary syndrome	0.00149	0.0041	CbGpPWpGaD
Gadoxetate—ABCC3—Transmembrane transport of small molecules—TRPV6—polycystic ovary syndrome	0.00148	0.00409	CbGpPWpGaD
Gadoxetate—ABCC3—Metabolism of lipids and lipoproteins—AKR1C2—polycystic ovary syndrome	0.00141	0.00389	CbGpPWpGaD
Gadoxetate—ABCC3—Metabolism of lipids and lipoproteins—TEAD2—polycystic ovary syndrome	0.00141	0.00389	CbGpPWpGaD
Gadoxetate—ABCC4—NRF2 pathway—SLC2A4—polycystic ovary syndrome	0.0014	0.00385	CbGpPWpGaD
Gadoxetate—ABCC4—Transmembrane transport of small molecules—TRPV6—polycystic ovary syndrome	0.00139	0.00384	CbGpPWpGaD
Gadoxetate—ABCC3—Transmembrane transport of small molecules—SCNN1A—polycystic ovary syndrome	0.00134	0.0037	CbGpPWpGaD
Gadoxetate—SLCO1B1—Metabolism of lipids and lipoproteins—LPCAT2—polycystic ovary syndrome	0.00133	0.00366	CbGpPWpGaD
Gadoxetate—SLCO1B3—Metabolism of lipids and lipoproteins—PNPLA2—polycystic ovary syndrome	0.00131	0.00361	CbGpPWpGaD
Gadoxetate—ABCC4—Transmembrane transport of small molecules—SCNN1A—polycystic ovary syndrome	0.00126	0.00348	CbGpPWpGaD
Gadoxetate—SLCO1B3—Metabolism of lipids and lipoproteins—SRD5A1—polycystic ovary syndrome	0.00124	0.00342	CbGpPWpGaD
Gadoxetate—ABCC4—Platelet degranulation—IGF1—polycystic ovary syndrome	0.00123	0.00339	CbGpPWpGaD
Gadoxetate—SLCO1B3—Metabolism of lipids and lipoproteins—STAR—polycystic ovary syndrome	0.00118	0.00327	CbGpPWpGaD
Gadoxetate—ABCC3—Metabolism of lipids and lipoproteins—PNPLA2—polycystic ovary syndrome	0.00118	0.00326	CbGpPWpGaD
Gadoxetate—ABCC2—NRF2 pathway—SLC2A4—polycystic ovary syndrome	0.00118	0.00325	CbGpPWpGaD
Gadoxetate—ABCC2—Transmembrane transport of small molecules—TRPV6—polycystic ovary syndrome	0.00118	0.00324	CbGpPWpGaD
Gadoxetate—ABCC4—Response to elevated platelet cytosolic Ca2+—IGF1—polycystic ovary syndrome	0.00117	0.00323	CbGpPWpGaD
Gadoxetate—ABCC4—Platelet degranulation—SERPINE1—polycystic ovary syndrome	0.00117	0.00322	CbGpPWpGaD
Gadoxetate—ABCC3—NRF2 pathway—NRG1—polycystic ovary syndrome	0.00117	0.00321	CbGpPWpGaD
Gadoxetate—ABCC3—Metabolism of lipids and lipoproteins—SRD5A1—polycystic ovary syndrome	0.00112	0.00309	CbGpPWpGaD
Gadoxetate—ABCC4—Response to elevated platelet cytosolic Ca2+—SERPINE1—polycystic ovary syndrome	0.00111	0.00306	CbGpPWpGaD
Gadoxetate—SLCO1B1—Transmembrane transport of small molecules—TRPV6—polycystic ovary syndrome	0.0011	0.00304	CbGpPWpGaD
Gadoxetate—ABCC4—NRF2 pathway—NRG1—polycystic ovary syndrome	0.0011	0.00302	CbGpPWpGaD
Gadoxetate—ABCC4—Hemostasis—PDE3B—polycystic ovary syndrome	0.00108	0.00298	CbGpPWpGaD
Gadoxetate—ABCC3—Metabolism of lipids and lipoproteins—STAR—polycystic ovary syndrome	0.00107	0.00295	CbGpPWpGaD
Gadoxetate—ABCC2—Transmembrane transport of small molecules—SCNN1A—polycystic ovary syndrome	0.00106	0.00293	CbGpPWpGaD
Gadoxetate—SLCO1B1—Metabolism of lipids and lipoproteins—AKR1C2—polycystic ovary syndrome	0.00105	0.0029	CbGpPWpGaD
Gadoxetate—SLCO1B1—Metabolism of lipids and lipoproteins—TEAD2—polycystic ovary syndrome	0.00105	0.0029	CbGpPWpGaD
Gadoxetate—SLCO1B3—SLC-mediated transmembrane transport—SLC2A4—polycystic ovary syndrome	0.00104	0.00286	CbGpPWpGaD
Gadoxetate—SLCO1B3—Metabolism of lipids and lipoproteins—HSD3B1—polycystic ovary syndrome	0.00101	0.00278	CbGpPWpGaD
Gadoxetate—SLCO1B1—Transmembrane transport of small molecules—SCNN1A—polycystic ovary syndrome	0.000999	0.00275	CbGpPWpGaD
Gadoxetate—SLCO1B3—Metabolism—NMNAT3—polycystic ovary syndrome	0.000963	0.00265	CbGpPWpGaD
Gadoxetate—ABCC4—Hemostasis—RACGAP1—polycystic ovary syndrome	0.000925	0.00255	CbGpPWpGaD
Gadoxetate—ABCC2—NRF2 pathway—NRG1—polycystic ovary syndrome	0.000924	0.00255	CbGpPWpGaD
Gadoxetate—SLCO1B3—Metabolism of lipids and lipoproteins—LHB—polycystic ovary syndrome	0.000919	0.00253	CbGpPWpGaD
Gadoxetate—ABCC3—Metabolism of lipids and lipoproteins—HSD3B1—polycystic ovary syndrome	0.000909	0.00251	CbGpPWpGaD
Gadoxetate—SLCO1B3—Metabolism of lipids and lipoproteins—HSD3B2—polycystic ovary syndrome	0.000898	0.00248	CbGpPWpGaD
Gadoxetate—SLCO1B3—Metabolism—LPCAT2—polycystic ovary syndrome	0.000881	0.00243	CbGpPWpGaD
Gadoxetate—SLCO1B3—Metabolism—SUOX—polycystic ovary syndrome	0.000881	0.00243	CbGpPWpGaD
Gadoxetate—SLCO1B1—Metabolism of lipids and lipoproteins—PNPLA2—polycystic ovary syndrome	0.00088	0.00243	CbGpPWpGaD
Gadoxetate—SLCO1B3—Metabolism of lipids and lipoproteins—AKR1C1—polycystic ovary syndrome	0.000869	0.0024	CbGpPWpGaD
Gadoxetate—ABCC3—Metabolism—NMNAT3—polycystic ovary syndrome	0.000869	0.0024	CbGpPWpGaD
Gadoxetate—SLCO1B1—Metabolism of lipids and lipoproteins—SRD5A1—polycystic ovary syndrome	0.000834	0.0023	CbGpPWpGaD
Gadoxetate—ABCC3—Metabolism of lipids and lipoproteins—LHB—polycystic ovary syndrome	0.000829	0.00229	CbGpPWpGaD
Gadoxetate—SLCO1B3—Metabolism—ISYNA1—polycystic ovary syndrome	0.000819	0.00226	CbGpPWpGaD
Gadoxetate—ABCC3—Metabolism of lipids and lipoproteins—HSD3B2—polycystic ovary syndrome	0.00081	0.00223	CbGpPWpGaD
Gadoxetate—ABCC4—Platelet degranulation—VEGFA—polycystic ovary syndrome	0.000802	0.00221	CbGpPWpGaD
Gadoxetate—SLCO1B3—Metabolism of lipids and lipoproteins—SULT2A1—polycystic ovary syndrome	0.0008	0.00221	CbGpPWpGaD
Gadoxetate—SLCO1B1—Metabolism of lipids and lipoproteins—STAR—polycystic ovary syndrome	0.000796	0.00219	CbGpPWpGaD
Gadoxetate—ABCC3—Metabolism—SUOX—polycystic ovary syndrome	0.000795	0.00219	CbGpPWpGaD
Gadoxetate—ABCC3—Metabolism—LPCAT2—polycystic ovary syndrome	0.000795	0.00219	CbGpPWpGaD
Gadoxetate—ABCC3—Metabolism of lipids and lipoproteins—AKR1C1—polycystic ovary syndrome	0.000785	0.00216	CbGpPWpGaD
Gadoxetate—ABCC4—Response to elevated platelet cytosolic Ca2+—VEGFA—polycystic ovary syndrome	0.000764	0.00211	CbGpPWpGaD
Gadoxetate—SLCO1B3—Metabolism of lipids and lipoproteins—YAP1—polycystic ovary syndrome	0.000747	0.00206	CbGpPWpGaD
Gadoxetate—ABCC3—Metabolism—ISYNA1—polycystic ovary syndrome	0.000739	0.00204	CbGpPWpGaD
Gadoxetate—ABCC3—Metabolism of lipids and lipoproteins—SULT2A1—polycystic ovary syndrome	0.000722	0.00199	CbGpPWpGaD
Gadoxetate—SLCO1B3—Metabolism of lipids and lipoproteins—CYP11A1—polycystic ovary syndrome	0.000709	0.00195	CbGpPWpGaD
Gadoxetate—SLCO1B1—SLC-mediated transmembrane transport—SLC2A4—polycystic ovary syndrome	0.000697	0.00192	CbGpPWpGaD
Gadoxetate—SLCO1B3—Metabolism—AKR1C2—polycystic ovary syndrome	0.000696	0.00192	CbGpPWpGaD
Gadoxetate—SLCO1B3—Metabolism—TEAD2—polycystic ovary syndrome	0.000696	0.00192	CbGpPWpGaD
Gadoxetate—SLCO1B1—Metabolism of lipids and lipoproteins—HSD3B1—polycystic ovary syndrome	0.000677	0.00187	CbGpPWpGaD
Gadoxetate—ABCC3—Metabolism of lipids and lipoproteins—YAP1—polycystic ovary syndrome	0.000674	0.00186	CbGpPWpGaD
Gadoxetate—SLCO1B3—Metabolism of lipids and lipoproteins—AKR1C3—polycystic ovary syndrome	0.000669	0.00185	CbGpPWpGaD
Gadoxetate—SLCO1B3—Metabolism of lipids and lipoproteins—CYP17A1—polycystic ovary syndrome	0.000659	0.00182	CbGpPWpGaD
Gadoxetate—SLCO1B1—Metabolism—NMNAT3—polycystic ovary syndrome	0.000647	0.00178	CbGpPWpGaD
Gadoxetate—ABCC3—Metabolism of lipids and lipoproteins—CYP11A1—polycystic ovary syndrome	0.00064	0.00176	CbGpPWpGaD
Gadoxetate—ABCC3—Metabolism—TEAD2—polycystic ovary syndrome	0.000628	0.00173	CbGpPWpGaD
Gadoxetate—ABCC3—Metabolism—AKR1C2—polycystic ovary syndrome	0.000628	0.00173	CbGpPWpGaD
Gadoxetate—SLCO1B3—Transmembrane transport of small molecules—TFRC—polycystic ovary syndrome	0.00062	0.00171	CbGpPWpGaD
Gadoxetate—SLCO1B1—Metabolism of lipids and lipoproteins—LHB—polycystic ovary syndrome	0.000617	0.0017	CbGpPWpGaD
Gadoxetate—ABCC3—Metabolism of lipids and lipoproteins—AKR1C3—polycystic ovary syndrome	0.000604	0.00167	CbGpPWpGaD
Gadoxetate—SLCO1B1—Metabolism of lipids and lipoproteins—HSD3B2—polycystic ovary syndrome	0.000603	0.00166	CbGpPWpGaD
Gadoxetate—ABCC3—Metabolism of lipids and lipoproteins—CYP17A1—polycystic ovary syndrome	0.000595	0.00164	CbGpPWpGaD
Gadoxetate—SLCO1B1—Metabolism—LPCAT2—polycystic ovary syndrome	0.000592	0.00163	CbGpPWpGaD
Gadoxetate—SLCO1B1—Metabolism—SUOX—polycystic ovary syndrome	0.000592	0.00163	CbGpPWpGaD
Gadoxetate—SLCO1B1—Metabolism of lipids and lipoproteins—AKR1C1—polycystic ovary syndrome	0.000584	0.00161	CbGpPWpGaD
Gadoxetate—SLCO1B3—Metabolism—PNPLA2—polycystic ovary syndrome	0.000583	0.00161	CbGpPWpGaD
Gadoxetate—SLCO1B3—Transmembrane transport of small molecules—PLAT—polycystic ovary syndrome	0.000577	0.00159	CbGpPWpGaD
Gadoxetate—ABCC4—Hemostasis—PLAT—polycystic ovary syndrome	0.000565	0.00156	CbGpPWpGaD
Gadoxetate—ABCC3—Transmembrane transport of small molecules—TFRC—polycystic ovary syndrome	0.00056	0.00154	CbGpPWpGaD
Gadoxetate—SLCO1B3—Metabolism—SRD5A1—polycystic ovary syndrome	0.000553	0.00152	CbGpPWpGaD
Gadoxetate—SLCO1B1—Metabolism—ISYNA1—polycystic ovary syndrome	0.00055	0.00152	CbGpPWpGaD
Gadoxetate—ABCC4—Platelet activation, signaling and aggregation—IGF1—polycystic ovary syndrome	0.000545	0.0015	CbGpPWpGaD
Gadoxetate—ABCC4—Platelet activation, signaling and aggregation—AKT2—polycystic ovary syndrome	0.000545	0.0015	CbGpPWpGaD
Gadoxetate—SLCO1B1—Metabolism of lipids and lipoproteins—SULT2A1—polycystic ovary syndrome	0.000538	0.00148	CbGpPWpGaD
Gadoxetate—SLCO1B3—Metabolism—STAR—polycystic ovary syndrome	0.000528	0.00145	CbGpPWpGaD
Gadoxetate—SLCO1B3—Transmembrane transport of small molecules—SLC2A4—polycystic ovary syndrome	0.000527	0.00145	CbGpPWpGaD
Gadoxetate—ABCC3—Metabolism—PNPLA2—polycystic ovary syndrome	0.000526	0.00145	CbGpPWpGaD
Gadoxetate—ABCC4—Transmembrane transport of small molecules—TFRC—polycystic ovary syndrome	0.000526	0.00145	CbGpPWpGaD
Gadoxetate—SLCO1B3—Metabolism of lipids and lipoproteins—CYP19A1—polycystic ovary syndrome	0.000521	0.00144	CbGpPWpGaD
Gadoxetate—ABCC3—Transmembrane transport of small molecules—PLAT—polycystic ovary syndrome	0.00052	0.00143	CbGpPWpGaD
Gadoxetate—ABCC4—Platelet activation, signaling and aggregation—SERPINE1—polycystic ovary syndrome	0.000517	0.00143	CbGpPWpGaD
Gadoxetate—SLCO1B1—Metabolism of lipids and lipoproteins—YAP1—polycystic ovary syndrome	0.000502	0.00138	CbGpPWpGaD
Gadoxetate—ABCC3—Metabolism—SRD5A1—polycystic ovary syndrome	0.000499	0.00138	CbGpPWpGaD
Gadoxetate—ABCC4—Transmembrane transport of small molecules—PLAT—polycystic ovary syndrome	0.000489	0.00135	CbGpPWpGaD
Gadoxetate—SLCO1B1—Metabolism of lipids and lipoproteins—CYP11A1—polycystic ovary syndrome	0.000476	0.00131	CbGpPWpGaD
Gadoxetate—ABCC3—Metabolism—STAR—polycystic ovary syndrome	0.000476	0.00131	CbGpPWpGaD
Gadoxetate—ABCC3—Transmembrane transport of small molecules—SLC2A4—polycystic ovary syndrome	0.000476	0.00131	CbGpPWpGaD
Gadoxetate—ABCC3—Metabolism of lipids and lipoproteins—CYP19A1—polycystic ovary syndrome	0.000471	0.0013	CbGpPWpGaD
Gadoxetate—SLCO1B3—Metabolism—HMMR—polycystic ovary syndrome	0.00047	0.0013	CbGpPWpGaD
Gadoxetate—SLCO1B1—Metabolism—TEAD2—polycystic ovary syndrome	0.000468	0.00129	CbGpPWpGaD
Gadoxetate—SLCO1B1—Metabolism—AKR1C2—polycystic ovary syndrome	0.000468	0.00129	CbGpPWpGaD
Gadoxetate—SLCO1B1—Metabolism of lipids and lipoproteins—AKR1C3—polycystic ovary syndrome	0.00045	0.00124	CbGpPWpGaD
Gadoxetate—SLCO1B3—Metabolism—HSD3B1—polycystic ovary syndrome	0.000449	0.00124	CbGpPWpGaD
Gadoxetate—ABCC4—Transmembrane transport of small molecules—SLC2A4—polycystic ovary syndrome	0.000447	0.00123	CbGpPWpGaD
Gadoxetate—ABCC2—Transmembrane transport of small molecules—TFRC—polycystic ovary syndrome	0.000444	0.00122	CbGpPWpGaD
Gadoxetate—SLCO1B3—Metabolism of lipids and lipoproteins—NCOR1—polycystic ovary syndrome	0.000443	0.00122	CbGpPWpGaD
Gadoxetate—SLCO1B1—Metabolism of lipids and lipoproteins—CYP17A1—polycystic ovary syndrome	0.000443	0.00122	CbGpPWpGaD
Gadoxetate—SLCO1B3—Transmembrane transport of small molecules—GNAS—polycystic ovary syndrome	0.000443	0.00122	CbGpPWpGaD
Gadoxetate—ABCC4—Hemostasis—GNAS—polycystic ovary syndrome	0.000434	0.0012	CbGpPWpGaD
Gadoxetate—ABCC3—Metabolism—HMMR—polycystic ovary syndrome	0.000424	0.00117	CbGpPWpGaD
Gadoxetate—SLCO1B3—Metabolism of lipids and lipoproteins—CYP1A1—polycystic ovary syndrome	0.00042	0.00116	CbGpPWpGaD
Gadoxetate—SLCO1B1—Transmembrane transport of small molecules—TFRC—polycystic ovary syndrome	0.000417	0.00115	CbGpPWpGaD
Gadoxetate—ABCC2—Transmembrane transport of small molecules—PLAT—polycystic ovary syndrome	0.000412	0.00114	CbGpPWpGaD
Gadoxetate—SLCO1B3—Metabolism—LHB—polycystic ovary syndrome	0.000409	0.00113	CbGpPWpGaD
Gadoxetate—ABCC3—Metabolism—HSD3B1—polycystic ovary syndrome	0.000405	0.00112	CbGpPWpGaD
Gadoxetate—ABCC3—Metabolism of lipids and lipoproteins—NCOR1—polycystic ovary syndrome	0.0004	0.0011	CbGpPWpGaD
Gadoxetate—SLCO1B3—Metabolism—HSD3B2—polycystic ovary syndrome	0.0004	0.0011	CbGpPWpGaD
Gadoxetate—ABCC3—Transmembrane transport of small molecules—GNAS—polycystic ovary syndrome	0.000399	0.0011	CbGpPWpGaD
Gadoxetate—SLCO1B1—Metabolism—PNPLA2—polycystic ovary syndrome	0.000392	0.00108	CbGpPWpGaD
Gadoxetate—SLCO1B1—Transmembrane transport of small molecules—PLAT—polycystic ovary syndrome	0.000387	0.00107	CbGpPWpGaD
Gadoxetate—SLCO1B3—Metabolism—AKR1C1—polycystic ovary syndrome	0.000387	0.00107	CbGpPWpGaD
Gadoxetate—ABCC3—Metabolism of lipids and lipoproteins—CYP1A1—polycystic ovary syndrome	0.000379	0.00105	CbGpPWpGaD
Gadoxetate—ABCC2—Transmembrane transport of small molecules—SLC2A4—polycystic ovary syndrome	0.000377	0.00104	CbGpPWpGaD
Gadoxetate—ABCC4—Transmembrane transport of small molecules—GNAS—polycystic ovary syndrome	0.000375	0.00104	CbGpPWpGaD
Gadoxetate—SLCO1B1—Metabolism—SRD5A1—polycystic ovary syndrome	0.000372	0.00102	CbGpPWpGaD
Gadoxetate—ABCC3—Metabolism—LHB—polycystic ovary syndrome	0.000369	0.00102	CbGpPWpGaD
Gadoxetate—ABCC3—Metabolism—HSD3B2—polycystic ovary syndrome	0.000361	0.000995	CbGpPWpGaD
Gadoxetate—SLCO1B3—Metabolism—SULT2A1—polycystic ovary syndrome	0.000356	0.000983	CbGpPWpGaD
Gadoxetate—ABCC4—Platelet activation, signaling and aggregation—VEGFA—polycystic ovary syndrome	0.000356	0.000981	CbGpPWpGaD
Gadoxetate—SLCO1B1—Metabolism—STAR—polycystic ovary syndrome	0.000354	0.000977	CbGpPWpGaD
Gadoxetate—SLCO1B1—Transmembrane transport of small molecules—SLC2A4—polycystic ovary syndrome	0.000354	0.000977	CbGpPWpGaD
Gadoxetate—SLCO1B1—Metabolism of lipids and lipoproteins—CYP19A1—polycystic ovary syndrome	0.00035	0.000966	CbGpPWpGaD
Gadoxetate—ABCC3—Metabolism—AKR1C1—polycystic ovary syndrome	0.000349	0.000963	CbGpPWpGaD
Gadoxetate—SLCO1B3—Metabolism—RRM2—polycystic ovary syndrome	0.000345	0.000952	CbGpPWpGaD
Gadoxetate—SLCO1B3—Metabolism—YAP1—polycystic ovary syndrome	0.000333	0.000917	CbGpPWpGaD
Gadoxetate—ABCC3—Metabolism—SULT2A1—polycystic ovary syndrome	0.000322	0.000887	CbGpPWpGaD
Gadoxetate—SLCO1B3—Metabolism—NAMPT—polycystic ovary syndrome	0.00032	0.000881	CbGpPWpGaD
Gadoxetate—SLCO1B3—Metabolism of lipids and lipoproteins—PPARG—polycystic ovary syndrome	0.000318	0.000876	CbGpPWpGaD
Gadoxetate—ABCC2—Transmembrane transport of small molecules—GNAS—polycystic ovary syndrome	0.000317	0.000873	CbGpPWpGaD
Gadoxetate—SLCO1B1—Metabolism—HMMR—polycystic ovary syndrome	0.000316	0.000871	CbGpPWpGaD
Gadoxetate—SLCO1B3—Metabolism—CYP11A1—polycystic ovary syndrome	0.000316	0.00087	CbGpPWpGaD
Gadoxetate—SLCO1B3—Metabolism of lipids and lipoproteins—POMC—polycystic ovary syndrome	0.000313	0.000864	CbGpPWpGaD
Gadoxetate—ABCC3—Metabolism—RRM2—polycystic ovary syndrome	0.000311	0.000859	CbGpPWpGaD
Gadoxetate—SLCO1B1—Metabolism—HSD3B1—polycystic ovary syndrome	0.000301	0.000831	CbGpPWpGaD
Gadoxetate—ABCC3—Metabolism—YAP1—polycystic ovary syndrome	0.0003	0.000828	CbGpPWpGaD
Gadoxetate—SLCO1B3—Metabolism—AKR1C3—polycystic ovary syndrome	0.000298	0.000822	CbGpPWpGaD
Gadoxetate—SLCO1B1—Metabolism of lipids and lipoproteins—NCOR1—polycystic ovary syndrome	0.000298	0.000821	CbGpPWpGaD
Gadoxetate—SLCO1B1—Transmembrane transport of small molecules—GNAS—polycystic ovary syndrome	0.000297	0.00082	CbGpPWpGaD
Gadoxetate—SLCO1B3—Metabolism—CYP17A1—polycystic ovary syndrome	0.000293	0.000809	CbGpPWpGaD
Gadoxetate—ABCC3—Metabolism—NAMPT—polycystic ovary syndrome	0.000288	0.000795	CbGpPWpGaD
Gadoxetate—ABCC3—Metabolism of lipids and lipoproteins—PPARG—polycystic ovary syndrome	0.000287	0.000791	CbGpPWpGaD
Gadoxetate—ABCC3—Metabolism—CYP11A1—polycystic ovary syndrome	0.000285	0.000785	CbGpPWpGaD
Gadoxetate—ABCC3—Metabolism of lipids and lipoproteins—POMC—polycystic ovary syndrome	0.000283	0.00078	CbGpPWpGaD
Gadoxetate—SLCO1B1—Metabolism of lipids and lipoproteins—CYP1A1—polycystic ovary syndrome	0.000282	0.000779	CbGpPWpGaD
Gadoxetate—ABCC4—Hemostasis—IGF1—polycystic ovary syndrome	0.000281	0.000775	CbGpPWpGaD
Gadoxetate—ABCC4—Hemostasis—AKT2—polycystic ovary syndrome	0.000281	0.000774	CbGpPWpGaD
Gadoxetate—SLCO1B1—Metabolism—LHB—polycystic ovary syndrome	0.000275	0.000758	CbGpPWpGaD
Gadoxetate—ABCC3—Metabolism—AKR1C3—polycystic ovary syndrome	0.000269	0.000742	CbGpPWpGaD
Gadoxetate—SLCO1B1—Metabolism—HSD3B2—polycystic ovary syndrome	0.000269	0.000741	CbGpPWpGaD
Gadoxetate—ABCC4—Hemostasis—SERPINE1—polycystic ovary syndrome	0.000267	0.000735	CbGpPWpGaD
Gadoxetate—ABCC3—Metabolism—CYP17A1—polycystic ovary syndrome	0.000265	0.00073	CbGpPWpGaD
Gadoxetate—SLCO1B1—Metabolism—AKR1C1—polycystic ovary syndrome	0.00026	0.000717	CbGpPWpGaD
Gadoxetate—SLCO1B3—Metabolism—TH—polycystic ovary syndrome	0.000254	0.0007	CbGpPWpGaD
Gadoxetate—SLCO1B3—Metabolism—SLC2A4—polycystic ovary syndrome	0.000247	0.000681	CbGpPWpGaD
Gadoxetate—SLCO1B1—Metabolism—SULT2A1—polycystic ovary syndrome	0.000239	0.00066	CbGpPWpGaD
Gadoxetate—SLCO1B3—Metabolism—CYP19A1—polycystic ovary syndrome	0.000232	0.00064	CbGpPWpGaD
Gadoxetate—SLCO1B1—Metabolism—RRM2—polycystic ovary syndrome	0.000232	0.000639	CbGpPWpGaD
Gadoxetate—ABCC3—Metabolism—TH—polycystic ovary syndrome	0.000229	0.000632	CbGpPWpGaD
Gadoxetate—SLCO1B1—Metabolism—YAP1—polycystic ovary syndrome	0.000224	0.000616	CbGpPWpGaD
Gadoxetate—ABCC3—Metabolism—SLC2A4—polycystic ovary syndrome	0.000223	0.000614	CbGpPWpGaD
Gadoxetate—SLCO1B1—Metabolism—NAMPT—polycystic ovary syndrome	0.000215	0.000592	CbGpPWpGaD
Gadoxetate—SLCO1B1—Metabolism of lipids and lipoproteins—PPARG—polycystic ovary syndrome	0.000213	0.000589	CbGpPWpGaD
Gadoxetate—SLCO1B1—Metabolism—CYP11A1—polycystic ovary syndrome	0.000212	0.000585	CbGpPWpGaD
Gadoxetate—SLCO1B1—Metabolism of lipids and lipoproteins—POMC—polycystic ovary syndrome	0.000211	0.000581	CbGpPWpGaD
Gadoxetate—ABCC3—Metabolism—CYP19A1—polycystic ovary syndrome	0.00021	0.000578	CbGpPWpGaD
Gadoxetate—SLCO1B3—Metabolism—GNAS—polycystic ovary syndrome	0.000207	0.000572	CbGpPWpGaD
Gadoxetate—SLCO1B1—Metabolism—AKR1C3—polycystic ovary syndrome	0.0002	0.000552	CbGpPWpGaD
Gadoxetate—SLCO1B3—Metabolism—NCOR1—polycystic ovary syndrome	0.000197	0.000544	CbGpPWpGaD
Gadoxetate—SLCO1B1—Metabolism—CYP17A1—polycystic ovary syndrome	0.000197	0.000544	CbGpPWpGaD
Gadoxetate—SLCO1B3—Metabolism—CYP1A1—polycystic ovary syndrome	0.000187	0.000516	CbGpPWpGaD
Gadoxetate—ABCC3—Metabolism—GNAS—polycystic ovary syndrome	0.000187	0.000516	CbGpPWpGaD
Gadoxetate—ABCC4—Hemostasis—VEGFA—polycystic ovary syndrome	0.000183	0.000506	CbGpPWpGaD
Gadoxetate—ABCC3—Metabolism—NCOR1—polycystic ovary syndrome	0.000178	0.000491	CbGpPWpGaD
Gadoxetate—SLCO1B3—Metabolism—MTHFR—polycystic ovary syndrome	0.000175	0.000481	CbGpPWpGaD
Gadoxetate—SLCO1B1—Metabolism—TH—polycystic ovary syndrome	0.000171	0.00047	CbGpPWpGaD
Gadoxetate—ABCC3—Metabolism—CYP1A1—polycystic ovary syndrome	0.000169	0.000466	CbGpPWpGaD
Gadoxetate—SLCO1B1—Metabolism—SLC2A4—polycystic ovary syndrome	0.000166	0.000458	CbGpPWpGaD
Gadoxetate—ABCC3—Metabolism—MTHFR—polycystic ovary syndrome	0.000157	0.000434	CbGpPWpGaD
Gadoxetate—SLCO1B1—Metabolism—CYP19A1—polycystic ovary syndrome	0.000156	0.00043	CbGpPWpGaD
Gadoxetate—SLCO1B3—Metabolism—PPARG—polycystic ovary syndrome	0.000142	0.00039	CbGpPWpGaD
Gadoxetate—SLCO1B3—Metabolism—POMC—polycystic ovary syndrome	0.00014	0.000385	CbGpPWpGaD
Gadoxetate—SLCO1B1—Metabolism—GNAS—polycystic ovary syndrome	0.000139	0.000384	CbGpPWpGaD
Gadoxetate—SLCO1B3—Metabolism—INS—polycystic ovary syndrome	0.000139	0.000383	CbGpPWpGaD
Gadoxetate—SLCO1B1—Metabolism—NCOR1—polycystic ovary syndrome	0.000133	0.000366	CbGpPWpGaD
Gadoxetate—ABCC3—Metabolism—PPARG—polycystic ovary syndrome	0.000128	0.000352	CbGpPWpGaD
Gadoxetate—ABCC3—Metabolism—POMC—polycystic ovary syndrome	0.000126	0.000347	CbGpPWpGaD
Gadoxetate—SLCO1B1—Metabolism—CYP1A1—polycystic ovary syndrome	0.000126	0.000347	CbGpPWpGaD
Gadoxetate—ABCC3—Metabolism—INS—polycystic ovary syndrome	0.000125	0.000345	CbGpPWpGaD
Gadoxetate—SLCO1B1—Metabolism—MTHFR—polycystic ovary syndrome	0.000117	0.000323	CbGpPWpGaD
Gadoxetate—SLCO1B1—Metabolism—PPARG—polycystic ovary syndrome	9.51e-05	0.000262	CbGpPWpGaD
Gadoxetate—SLCO1B1—Metabolism—POMC—polycystic ovary syndrome	9.38e-05	0.000259	CbGpPWpGaD
Gadoxetate—SLCO1B1—Metabolism—INS—polycystic ovary syndrome	9.33e-05	0.000257	CbGpPWpGaD
